InnoMed Capital
VC Fund
InnoMed Capital is a VC fund focused on Medical and Biotechnology. InnoMed Capital
- Total investments:
- 6
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries InnoMed Capital invests in
Stages InnoMed Capital invests in
Countries InnoMed Capital invests in
Investment Focus
Industry
- Medical 3 (50%)
- Biotechnology 3 (50%)
- Manufacturing 2 (33%)
- Chemical 1 (17%)
- Biopharma 1 (17%)
Stage
- Series A 3 (50%)
- Seed 1 (17%)
- Angel 1 (17%)
- Series B 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lanboto
|
Lanboto is an animal health firm focused on the research and development, production, sales, and servicing of new pet medicines. | $14.2M / Series B / Jul 13, 2023 | |
Eaglenos
|
Eaglenos is an IVD company that specialises in medical POCT, home health care devices, and health management systems. It focuses on chemistry, materials, electronics, software, machinery, and biomedical engineering. It helps in the advancement of electrochemistry, microfluidics, signal acquisition, and automation technologies. | $21.2M / Series A / May 29, 2023 | |
|
Polarisic
|
PolarisIC develops depth perception and low-light imaging chip products. | $12.9M / Seed / Dec 14, 2022 | |
ChomiX Biotech
|
ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry. | $1.5M / Angel / Jul 15, 2021 | |
Novlead Biotech
|
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations. | Series A / Jan 01, 2021 | |
InxMed
|
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $19M / Series A / Sep 04, 2020 |
Co-Investors
Grand Yangtze Capital
2 deals together
3E Bioventures
1 deal together
China Growth Capital
1 deal together
Dami Ventures
1 deal together
Ennovation Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does InnoMed Capital invest in?
InnoMed Capital invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Series A and Seed stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did InnoMed Capital last invest?
The most recent investment recorded for InnoMed Capital closed in Jul 2023. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
